Vitamin D, Probiotics and Breast Cancer
- Conditions
- Breast Cancer.
- Registration Number
- IRCT20200313046756N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 88
Women over 18 years with clinical stage II and III breast cancer diagnosis.
Undergoing Neo-adjuvant Treatment and Surgery.
Age less than 18 years
Stages I and IV of Breast Cancer
BMI >30
Non-surgical advanced or metastatic cancers
Cancer with a Basal-like Molecular Pattern
Patients who have been taking vitamin D or probiotic supplements for the past three months.
People with hyperparathyroidism or hypoparathyroidism
active Kidney stones in the past six months
Renal Failure (Creatinine> 190mmol / L)
Hypercalcemia
History of taking part in other intervention tests.
Hormone therapy history.
History of radiotherapy
Recent use of estrogenic drugs such as birth control pills
Chronic diarrhea or constipation (over 4 consecutive weeks)
History of inflammatory bowel disease
Celiac disease, chronic pancreatitis, history of colectomy and ileostomy
History of gallstones
Liver Failures
Known cases of AIDS
Continuous and long-term use of antibiotics, consumption of aluminum hydroxate
History of Thiazide diuretics
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method